GELITA, a global leader in collagen proteins and pharmaceutical excipients, will present its latest innovations for softgel applications and bioscience solutions at CPhI 2026, taking place October 6–8, 2026, at Fiera Milano, Milan, Italy. Visitors are invited to meet GELITA’s experts at booth 16H65 and discover how specialized gelatin and collagen peptides-based excipients are enabling next-generation pharmaceutical and biomedical applications.
Advanced Softgel Specialty Solutions
GELITA’s Softgel Specialty Portfolio is designed to help manufacturers overcome critical formulation barriers. The portfolio includes solutions that enable rapid fill release, true enteric soft capsules, enhanced leakage prevention, and reduced crosslinking. These technologies provide greater formulation flexibility while supporting the stability and performance of sensitive active ingredients.
Endotoxin Controlled Excipients for Bioscience Applications
For emerging biomedical and pharmaceutical applications, GELITA offers a range of Endotoxin Controlled Excipients developed to meet the demanding requirements of advanced bioscience fields. These excipients are suitable for applications such as vaccine stabilization, regenerative medicine, 3D bioprinting, and medical devices. Through stringent endotoxin control, they help support product safety, reliability, and performance in highly specialized environments.
Meet the Experts
Visitors to booth 16H65 will have the opportunity to discuss their specific development challenges directly with specialists from the GELITA Pharma Institute. Through one-on-one consultations, the team will provide insights into formulation optimization and explore tailored solutions for pharmaceutical and bioscience projects.
Visit GELITA at CPhI 2026
Join GELITA at Fiera Milano from October 6–8, 2026, and discover how innovative excipient technologies are shaping the future of softgels, drug delivery, and bioscience applications.
Meet the team at booth 16H65.
